CVSS 3.1
7.1 highCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:NHigh (7.1) in philips clinical collaboration platform. EPSS 0.4% estimated probability of exploitation activity in the next 30 days.
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:NExplain CVE-2020-16247 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2020-16247?via=ask-ai-copy and https://cve.bz/cve/CVE-2020-16247?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2020-16247 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.
From the CNA's record in the CVE List.
| Product | Affected |
|---|---|
| Philips Clinical Collaboration Platform | before 12.2.1 |
| Advisory | Title | Published | Sectors | Affected | Fixed |
|---|---|---|---|---|---|
| ICSMA-20-261-01 | ICSMA-20-261-01_Philips Clinical Collaboration Platform | 2020-09-17 | Clinical Collaboration Platform: Versions 12.2.1 and prior | none listed |
From CISA's ICS advisories (CSAF), provided under CISA's notification. Only the facts are shown; each advisory is on CISA's page. Credits.